Purity ≥ 99%ARA-290 Cibinetide (undecapeptide)
- EPO-derived peptide
- ≥99% purity
- CoA per lot
Analytical-grade peptide reference material, supplied as a lyophilized powder for in-vitro laboratory research use only.
Quantity
Per vial$99 $79.20Halloween: 20% off
Bundle and bulk savings, codes and shipping are worked out in the cart at VNG.
Free shipping over $149 · CoA included with every order
About this material
Analytical-grade peptide reference material, supplied as a lyophilized powder for in-vitro laboratory research use only.
Lab report for every lot
Each lot ships with a Certificate of Analysis matched to its lot number: purity, identity, heavy metals, sterility and endotoxin.
Published research
- ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber densityMolecular medicine (Cambridge, Mass.), 2013
- ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetesMolecular medicine (Cambridge, Mass.), 2015
- ARA 290 relieves pathophysiological pain by targeting the TRPV1 channelPeptides, 2016
- Cibinetide dampens innate immune cell functions, ameliorating the course of experimental colitisScientific reports, 2017
- A phase 2 clinical trial on the use of cibinetide for the treatment of diabetic macular edemaJournal of clinical medicine, 2020
Research use only. Not for human or animal consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.
